SCYNEXIS, Inc. (SCYX) Stock Forecast & Price Target
Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)
Revenue and earnings estimates published by analysts covering SCYNEXIS, Inc. (SCYX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.
For SCYNEXIS, Inc., analysts forecast revenue rising from $9.94M in 2025 to $27.60M in 2030; the average estimate for 2030 earnings per share is −$2.96; with published estimates ranging from −$5.37 to −$1.29; 3 analysts contribute to these figures. These are forecasts published by analysts, not results.
Revenue forecast (USD)
The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.
Earnings per share forecast
SCYNEXIS, Inc. (SCYX) forecast — frequently asked questions
What are analysts forecasting for SCYNEXIS, Inc.'s earnings?
The average analyst estimate for SCYNEXIS, Inc. (SCYX) earnings per share in 2030 is -2.96, with individual estimates between -5.37 and -1.29.
How much revenue is SCYNEXIS, Inc. expected to make?
Analysts forecast SCYNEXIS, Inc. (SCYX) revenue of $27.60M in 2030, based on 2 published estimates.
How many analysts cover SCYX?
3 analysts contribute estimates for SCYNEXIS, Inc. (SCYX). Thin coverage makes an average less reliable.
Analyst forecasts for other Medical - Pharmaceuticals stocks
Popular Stocks
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.